Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis
Hung-Yuan Chen1, Wan-Chuan Tsai, Yen-Ling Chiu
1From the Division of Nephrology (H-YC, W-CT, Y-LC, S-PH, M-FP, J-YY, Y-SP), Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City; and Division of Nephrology (H-YC, Y-LC, S-PH, M-FP, J-YY, Y-SP), Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Insights
The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio predicts cardiovascular events and mortality in nondiabetic dialysis patients. This ratio is a valuable tool for assessing risk in this population.
Area of Science:
- Cardiology
- Nephrology
- Biochemistry
Background:
- The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an established marker of atherogenic dyslipidemia and cardiovascular risk in the general population.
- Its predictive value for cardiovascular (CV) outcomes and survival specifically in dialysis patients remains largely unknown.
Purpose of the Study:
- To investigate the association between the TG/HDL-C ratio and cardiovascular outcomes, including CV events, CV death, and all-cause mortality in dialysis patients.
- To determine if the TG/HDL-C ratio can serve as a reliable predictor of CV outcomes and survival in this specific patient group.
Main Methods:
- A prospective, observational cohort study involving 602 dialysis patients (539 hemodialysis, 63 peritoneal dialysis).
- Patients were followed for a median of 3.9 years, with outcomes including CV events, CV death, and all-cause mortality.
- Cox regression models, adjusted for demographic and inflammatory/nutritional markers, were used to analyze the association of baseline TG/HDL-C ratio with outcomes.
Main Results:
- Higher TG/HDL-C ratios were significantly associated with increased incidence of CV events (adjusted HR 2.03), CV mortality (adjusted HR 1.91), composite CV outcomes (adjusted HR 2.2), and all-cause mortality (adjusted HR 1.94) compared to the lowest quintile.
- These associations were observed in the overall dialysis population but not in diabetic dialysis patients.
- The TG/HDL-C ratio demonstrated predictive capability for CV outcomes and survival in nondiabetic dialysis patients.
Conclusions:
- The TG/HDL-C ratio is a valuable and accessible predictor of cardiovascular outcomes and survival in prevalent nondiabetic dialysis patients.
- The TG/HDL-C ratio does not appear to predict cardiovascular outcomes in dialysis patients with diabetes.
- This ratio can aid clinicians in risk stratification for cardiovascular disease in nondiabetic individuals undergoing dialysis.
Abstract:
Triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, an indicator of atherogenic dyslipidemia, is a predictor of cardiovascular (CV) outcomes in the general population and has been correlated with atherosclerotic events. Whether the TG/HDL-C ratio can predict CV outcomes and survival in dialysis patients is unknown. We performed this prospective, observational cohort study and enrolled 602 dialysis patients (539 hemodialysis and 63 peritoneal dialysis) from a single center in Taiwan followed up for a median of 3.9 years. The outcomes were the occurrence of CV events, CV death, and all-cause mortality during follow-up. The association of baseline TG/HDL-C ratio with outcomes was explored with Cox regression models, which were adjusted for demographic parameters and inflammatory/nutritional markers. Overall, 203 of the patients experienced CV events and 169 patients died, of whom 104 died due to CV events. Two hundred fifty-four patients reached the composite CV outcome. Patients with higher TG/HDL-C levels (quintile 5) had a higher incidence of CV events (adjusted hazard ratio [HR] 2.03, 95% confidence interval [CI] 1.19-3.47), CV mortality (adjusted HR 1.91, 95% CI 1.07-3.99), composite CV outcome (adjusted HR 2.2, 95% CI 1.37-3.55), and all-cause mortality (adjusted HR 1.94, 95% CI 1.1-3.39) compared with the patients in quintile 1. However, in diabetic dialysis patients, the TG/HDL-C ratio did not predict the outcomes. The TG/HDL-C ratio is a reliable and easily accessible predictor to evaluate CV outcomes and survival in prevalent nondiabetic dialysis patients. ClinicalTrials.gov: NCT01457625.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...


